The award will go toward the development of MicrobeDx's technology for detecting the presence of bacteria in clinical urine specimens and to which antibiotics they are susceptible.
The funds will be used to develop personalized treatments through collaborations within the Boston community, speed up clinical trials, and remove data bottlenecks.
With funding from CurePSP, the collaborators will investigate the genetic causes of the disease, which affects a patients' speech, mobility, balance, and other abilities.
Parlaying expertise in genetics, pathology, radiology, immunology, and gastroenterology, the center will focus on personalized medicine for Crohn's disease.
Under a pilot run, CytoVale, a developer of technologies for high-throughput single-cell analysis, has received funding and been assigned a mentor from BD.
Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.
A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.
